1 Introduction 12
1.1 Industry Definition and Research Scope 12
1.1.1 Industry Definition 12
1.1.2 Research Scope 13
1.2 Research Methodology 16
1.2.1 Overview of Market Research Methodology 16
1.2.2 Market Assumption 17
1.2.3 Secondary Data 17
1.2.4 Primary Data 17
1.2.5 Data Filtration and Model Design 18
1.2.6 Market Size/Share Estimation 19
1.2.7 Research Limitations 20
1.3 Executive Summary 21
2 Market Overview and Dynamics 24
2.1 Market Size and Forecast 24
2.1.1 Impact of COVID-19 on World Economy 25
2.1.2 Impact of COVID-19 on the Market 29
2.1.3 Impact of Russia-Ukraine Conflict 31
2.1.4 Impact of Israel-Palestine War 33
2.2 Major Growth Drivers 34
2.3 Market Restraints and Challenges 39
2.4 Emerging Opportunities and Market Trends 42
2.5 Porter's Fiver Forces Analysis 45
3 Segmentation of Global Market by Product 49
3.1 Market Overview by Product 49
3.2 Recombinant Albumin (rAlbumin) 52
3.3 Recombinant Insulin (rInsulin) 53
3.4 Recombinant Epidermal Growth Factor (rEGF) 54
3.5 Recombinant Interleukin Growth Factor (rILGF) 55
3.6 Recombinant Transferrin (rTransferrin) 56
3.7 Recombinant Trypsin (rTrypsin) 57
3.8 Recombinant Insulin-like Growth Factor (rIGF) 58
3.9 Recombinant Stem Cell Factor (rSCF) 59
3.10 Recombinant Aprotinin (rAprotinin) 60
3.11 Recombinant Lysozyme (rLysozyme) 61
3.12 Other Products 62
4 Segmentation of Global Market by Source 63
4.1 Market Overview by Source 63
4.2 Animals 66
4.3 Human 67
4.4 Microorganisms 68
5 Segmentation of Global Market by Expression System 69
5.1 Market Overview by Expression System 69
5.2 Mammalian 72
5.3 E. Coli 73
5.4 Yeast 74
5.5 Other Expression Systems 75
6 Segmentation of Global Market by Application 76
6.1 Market Overview by Application 76
6.2 Stem Cell and Regenerative Medicine 79
6.2.1 Stem Cell Therapies 80
6.2.2 Cell Therapies 81
6.2.3 Gene Therapies and Others 82
6.3 Bio-Production 83
6.3.1 Monoclonal Antibodies 85
6.3.2 Recombinant Proteins 86
6.3.3 Hormones 87
6.3.4 Vaccines 88
6.3.5 Other Biological Products 89
6.4 Academic Research 90
7 Segmentation of Global Market by End User 91
7.1 Market Overview by End User 91
7.2 Biopharmaceutical Companies 94
7.3 Contract Research Centers (CROs) 95
7.4 Academic & Research Institutes 96
8 Segmentation of Global Market by Region 97
8.1 Geographic Market Overview 2023-2033 97
8.2 North America Market 2023-2033 by Country 102
8.2.1 Overview of North America Market 102
8.2.2 U.S. 106
8.2.3 Canada 110
8.2.4 Mexico 113
8.3 European Market 2023-2033 by Country 116
8.3.1 Overview of European Market 116
8.3.2 Germany 120
8.3.3 U.K. 123
8.3.4 France 126
8.3.5 Spain 129
8.3.6 Italy 132
8.3.7 Russia 135
8.3.8 Rest of European Market 138
8.4 Asia-Pacific Market 2023-2033 by Country 140
8.4.1 Overview of Asia-Pacific Market 140
8.4.2 Japan 144
8.4.3 China 148
8.4.4 Australia 151
8.4.5 India 154
8.4.6 South Korea 157
8.4.7 Rest of APAC Region 160
8.5 South America Market 2023-2033 by Country 162
8.5.1 Argentina 166
8.5.2 Brazil 169
8.5.3 Chile 172
8.5.4 Rest of South America Market 175
8.6 MEA Market 2023-2033 by Country 176
8.6.1 UAE 180
8.6.2 Saudi Arabia 183
8.6.3 South Africa 186
8.6.4 Other National Markets 189
9 Competitive Landscape 190
9.1 Overview of Key Vendors 190
9.2 New Product Launch, Partnership, Investment, and M&A 193
9.3 Company Profiles 194
Abcam plc. 194
BBI Solutions OEM Limited 196
Becton, Dickinson and Company 197
Cell Sciences, Inc. 198
Corning Incorporated 199
F. Hoffmann-La Roche Ltd. 200
FUJIFILM Irvine Scientific, Inc. 201
Gemini Bioproducts, LLC 202
HiMedia Laboratories, LLC 203
InVitria 204
Kingfisher Biotech, Inc. 205
Lonza Group AG 206
Merck KGaA 207
Novus Biologicals, LLC 208
R&D Systems, Inc. 209
Sartorius AG 210
Sino Biological Inc. 211
STEMCELL Technologies Inc. 212
Thermo Fisher Scientific Inc. 213
10 Investing in Recombinant Cell Culture Supplements Industry: Risk Assessment and Management 214
10.1 Risk Evaluation of Global Market 214
10.2 Critical Success Factors (CSFs) 221
RELATED REPORTS 224